Results 211 to 220 of about 10,992,361 (296)

Managing institutional conflicts: Stakeholder accounts of communication between conflict of interest and technology transfer offices. [PDF]

PLoS One
McCoy MS, Ward M, Neergaard R, Joffe S, Szymczak JE.   +4 more
europepmc   +1 more source

KDAC6 alters cell morphology and motility through positive and negative modulation of F‐actin distribution

FEBS Open Bio, EarlyView.
KDAC6 has been associated with cell motility and actin structures, but specific domain contributions are not established. The two catalytic domains have differential effects on motility and F‐actin regulation, affecting cortical F‐actin density, motility, stress fibers, and cell spreading.
Taylor V. Joseph, Andrea B. Pham, Kiara E. Bornes, Razan H. Hammad, Chelsea A. Rousseve‐Ross, Thomas M. Huckaba, Terry J. Watt, Tasha B. Toro   +7 more
wiley   +1 more source

University technology transfer and the role of technology transfer offices

, 2017
O Objeto desta tese é a Transferência de Tecnologia Universitária (UTT), isto é, os mecanismos da transferência de tecnologia entre as universidades e as empresas interessadas no uso do conhecimento gerado pelos investigadores universitários, e o papel dos Gabinetes de Transferência de Tecnologia (TTO) universitários, com base em três estudos ...
openaire   +1 more source

Organizational Network Analysis of SAMHSA's Technology Transfer Center (TTC) Network. [PDF]

J Behav Health Serv Res
Agley J, Gassman R, Reho K, Roberts J, Heil SKR, Golzarri-Arroyo L, Eddens K.   +6 more
europepmc   +1 more source

Accurate and noninvasive prostate cancer detection using plasma‐derived extracellular vesicle RNA

FEBS Open Bio, EarlyView.
Plasma extracellular vesicles were captured with WGA‐conjugated magnetic beads and profiled for RNA biomarkers. A three‐RNA panel (NM_024955, NR_047469, and NR_002564) distinguished prostate cancer from healthy controls and benign prostatic hyperplasia, supporting a simple, noninvasive approach to improve prostate cancer detection.
Hanping Wei, Haoran Wu, Wei Feng
wiley   +1 more source

Comparative assessment of a COVID-19 vaccine after technology transfer to Iran from critical quality attributes to clinical and immunogenicity aspects. [PDF]

Sci Rep
Doroud D, Sadat Larijani M, Biglari A, Ashrafian F, Sabouni T, Eybpoosh S, Verez-Bencomo V, Valdés-Balbín Y, García-Rivera D, Herrera-Rojas Y, Climent-Ruiz Y, Santana-Mederos D, Ramezani A.   +12 more
europepmc   +1 more source

Identifying and characterising a plant GH1 β‐glucosidase that exhibits hydrolytic activity on N‐linked glucopyranoside

FEBS Open Bio, EarlyView.
We report the first β‐glucosidase with demonstrated hydrolytic activity on an N‐linked glycopyranoside. The enzyme, native to maize, was biochemically characterised for this novel reaction, and structural modelling of the enzyme–substrate complex revealed several clues to the underlying reduced catalytic rate relative to its native O‐glycopyranoside ...
Hani Gharabli, Carlotta Chiesa, Maher Abou Hachem, Ditte Hededam Welner   +3 more
wiley   +1 more source

Exploring the current state of technology transfer in the United States: perspectives and improvement strategies from the experts. [PDF]

Front Res Metr Anal
Eidlisz J, von Simson I, Gold-von Simson G.   +2 more
europepmc   +1 more source

Structural studies and functional engineering of NanX: an anhydro‐sialic acid transporter from Escherichia coli

FEBS Open Bio, EarlyView.
Biophysical characterisation shows that NanX, a membrane transport protein from the major facilitator superfamily (MFS), forms both monomers and dimers after purification. AlphaFold modelling and substrate docking provide information on residues likely involved in substrate recognition for NanX and another MFS member, NanT.
Michael C. Newton‐Vesty, Kelsi R. Hall, Zachary D. Tillett, Liam S. Turk, James S. Davies, Michael J. Currie, Hamish G. Brown, Sepideh Valimehr, Peter D. Mace, Andrew E. Whitten, Santosh Panjikar, Eric Hanssen, Rachel A. North, Renwick C.J. Dobson   +13 more
wiley   +1 more source

Negotiation of new international health law on intellectual property, technology transfer, open science and pathogen access and benefit sharing: a textual and contextual analysis. [PDF]

BMJ Public Health
de Beer J, De Koker R.
europepmc   +1 more source